Search - tctmd.com

Displaying 1 - 20 of 20

Sort: Relevancy | Date

News Conference News TCT 2022

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

L.A. McKeown

September 23, 2022

Presentation TCT 2022

Valve Function Insights from Bench Testing

Presenter: Janarthanan Sathananthan

September 18, 2022

TAVR of Yesterday is not the TAVR of the Future

Presentation TCT 2022

TAVR of Yesterday is not the TAVR fo the Future

Presenter: Nicolas Van Mieghem

September 18, 2022

News Conference News TCT 2019

Early Mortality Rates After TAVR Halved in a Decade, With Some Gender Differences

L.A. McKeown

October 09, 2019

News Conference News TCT 2019

MitraClip Pricey but ‘Acceptable’ in COAPT Cost-Efficacy Analysis

Shelley Wood

September 29, 2019

News Conference News TCT 2019

Portico Noninferior to Commercial TAVR Valves in IDE Study

Caitlin E. Cox

September 27, 2019

News Conference News TCT 2017

Selection Bias? Debate Asks How Many TAVR Devices Centers Should Stock

Yael L. Maxwell

November 09, 2017

Presentation TCT 2016

PARTNER I FIVE-YEAR ECHO: Long-term Hemodynamic and Structural Outcomes After Transcatheter Aortic Valve Replacement in High-Risk and Inoperable Patients With Aortic Stenosis

Presenter: Gregg W. Stone, Philippe Pibarot, Pamela S. Douglas

November 01, 2016

Presentation TCT 2016

PARTNER II QUALITY OF LIFE: Health Status Benefits From a Prospective, Randomized Trial of Transcatheter and Surgical Aortic Valve Replacement in Intermediate-Risk Patients With Severe Aortic Stenosis

Presenter: Gregg W. Stone, Philippe Pibarot, David J. Cohen

November 01, 2016

News Conference News TCT 2015

First-in-Human Studies: Novel Devices for Aortic Valve Stenosis Safe, Feasible

October 12, 2015

Presentation TCT 2014

Regulatory Approval Pathways for Novel vs Iterative TAVR Devices: Back to the Future?

Presenter: Matthew G. Hillebrenner, Michael J. Mack, Daniel I. Simon, Nicole Ibrahim

September 16, 2014

Presentation TCT 2014

Novel Sheath Technology for TAVR

Presenter: Hemal Gada

September 15, 2014

Presentation TCT 2014

TCT 692: Multicenter Clinical Study Evaluating a Novel Resheathable Self-Expanding Transcatheter Aortic Valve System

Presenter: Valentin Fuster, Ganesh Manoharan

September 13, 2014

Presentation TCT 2013

TCT-106. Novel Hemodynamic Index for the Assessment of Aortic Regurgitation After Transcatheter Aortic Valve Replacement

Presenter: Baris Bugan

October 29, 2013

Presentation TCT 2013

First Experience With A Novel Anatomically Adapted Percutaneous Heart Valve For The Tricuspid Position

Presenter: Desiree Pott, Margarita Malasa, Maximilian Kuetting, Ute Urban, Jan Roggenkamp, Ulrich Steinseifer, Nima Hatam, R?diger Autschbach, Jan Spillner, Andrea Amerini

January 31, 2013

Presentation TCT 2013

A Novel Catheter-Based Mitral Valve Bio-Prosthesis Short Term Pre-Clinical Results

Presenter: Shmuel Banai, Marc Jolicoeur, Jean-Fran?ois Tanguay, Stefan Verheye, Christopher White, Elazer Edelman

January 31, 2013

Presentation TCT 2012

Novel Transapical Left Ventricular Access and Closure Devices

Presenter: Martin Leon

October 24, 2012

Presentation TCT 2012

A Novel Self-Expanding TAVR System: CENTERA

Presenter: Karl-Heinz Kuck

October 24, 2012

Presentation TCT 2012

A Novel Balloon-Expandable TAVR System for Aortic Regurgitation

Presenter: Jian Ye

October 24, 2012

Presentation TCT 2012

TCT-110: First Experience with a Novel Anatomically Adapted Percutaneous Heart Valve for the Tricuspid Position

Presenter: Desiree Pott

October 22, 2012

Advertisement

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

Valve Function Insights from Bench Testing

TAVR of Yesterday is not the TAVR fo the Future

Early Mortality Rates After TAVR Halved in a Decade, With Some Gender Differences

MitraClip Pricey but ‘Acceptable’ in COAPT Cost-Efficacy Analysis

Portico Noninferior to Commercial TAVR Valves in IDE Study

Selection Bias? Debate Asks How Many TAVR Devices Centers Should Stock

PARTNER I FIVE-YEAR ECHO: Long-term Hemodynamic and Structural Outcomes After Transcatheter Aortic Valve Replacement in High-Risk and Inoperable Patients With Aortic Stenosis

PARTNER II QUALITY OF LIFE: Health Status Benefits From a Prospective, Randomized Trial of Transcatheter and Surgical Aortic Valve Replacement in Intermediate-Risk Patients With Severe Aortic Stenosis

First-in-Human Studies: Novel Devices for Aortic Valve Stenosis Safe, Feasible

Regulatory Approval Pathways for Novel vs Iterative TAVR Devices: Back to the Future?

Novel Sheath Technology for TAVR

TCT 692: Multicenter Clinical Study Evaluating a Novel Resheathable Self-Expanding Transcatheter Aortic Valve System

TCT-106. Novel Hemodynamic Index for the Assessment of Aortic Regurgitation After Transcatheter Aortic Valve Replacement

First Experience With A Novel Anatomically Adapted Percutaneous Heart Valve For The Tricuspid Position

A Novel Catheter-Based Mitral Valve Bio-Prosthesis Short Term Pre-Clinical Results

Novel Transapical Left Ventricular Access and Closure Devices

A Novel Self-Expanding TAVR System: CENTERA

A Novel Balloon-Expandable TAVR System for Aortic Regurgitation

TCT-110: First Experience with a Novel Anatomically Adapted Percutaneous Heart Valve for the Tricuspid Position

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content